Current filters:  
Preslmayr Rechtsanwälte OG
The financing of the Austrian healthcare system by the social security institutions differs between the inpatient and the outpatient sector:
European Union
Arnold & Porter
Life sciences companies are doing their best to conduct business through remote customer interactions, and many expect that the expanded use of the technologies that facilitate...
Kilinc Law & Consulting
The Medical Device Directive ("MDD") of the European Council numbered 93/42/EEC, which came into force in 1993 and amended in 2007 with the Directive 2007/47 /EC...
Arnold & Porter
On 11 June 2020, the European Medicines Agency (EMA), during its Management Board meeting, has endorsed the methodology and next steps leading to the go-live of the Clinical Trials Information System...
Arnold & Porter
Although the date of application of the Medical Devices Regulation (MDR) has been delayed by a year, to May 2021, the EU institutions continue to work on its implementation to ensure that the new framework is workable...
KPMG Malta
As from 22 May, certain establishments will be allowed to resume business, subject to sector-specific health risks mitigation measures.
Caiado Guerreiro, Sociedade de Advogados
Ordinance No. 90-A/2020, of April 9, has just arrived and it brings about an exceptional and temporary regime for electronic prescription of medicines and respective medical prescriptions...
Caiado Guerreiro, Sociedade de Advogados
Go, go, go! Portugal has approved exceptional and temporary measures in the context of the Coronavirus – COVID 19, which include exceptional rules for Public Procurement aimed at the Health Sector.
Caiado Guerreiro, Sociedade de Advogados
Following the declaration by the World Health Organization of a world health emergency due to the infection by SARS-CoV-2, the Portuguese Drug Agency (INFARMED) has published a set of exceptional measures ...
Caiado Guerreiro, Sociedade de Advogados
Decree-Law No. 14-E/2020, of April 13, establishes an exceptional and temporary regime for the design, manufacture, import, national commercialisation and use of medical devices for human use...
Schoenherr Attorneys at Law
With growing expectations of a global recession generated by the COVID-19 pandemic, avoiding disruptions to the food supply chain and food production continues to be a priority.
Russian Federation
Gorodissky & Partners
The current global concerns over the Coronavirus pandemic create new challenges for industries, including the life sciences sector.
GRATA International
Производство медицинских изделий является ...
ELIG Gürkaynak Attorneys-at-Law
The Turkish Medicine and Medical Devices Agency ("Agency") of the Ministry of Health issued an announcement on April 27, 2020 updating the Guidelines for Scientific Meetings and Educational...
Brabners LLP
As with any business, clubs will wish to ensure that those who work for them, whether on or off the pitch...
Leigh Day
The man, who we are calling John, was employed by Greenwich and Bexley Area Health Authority.
Clyde & Co
NHS Resolution's claims mediation service was launched on 5 December 2016 and has since then proved extremely successful as a means of supporting patients..
Clyde & Co
The US Department of Justice announced on May 13 that Omnicare Inc., a subsidiary of CVS, has agreed to pay a $15.3 million civil penalty.
Marks & Clerk
Synthetic biology continues to be a disruptive technology in a number of key areas and represents a significant opportunity for R&D and development of IP, and hence investment.
1 July 2020 – The following is an overview of the current government measures concerning the life sciences and healthcare sectors in Bulgaria, the Czech Republic, Hungary, Kazakhstan, Romania...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Font Size:
Mondaq Social Media